Nivolumab Combined With SOX Used in the Perioperative Treatment
NCT05739045
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Immune Suppression
Gastric Cancer
Interventions
DRUG:
nivolumab combined with SOX
Sponsor
Xiangdong Cheng